Optimum Investment Advisors Vaxart, Inc. Transaction History

Optimum Investment Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 15, 2021	SELL	$5.64 - $23.33 $564 - $2,333	-100 Reduced 16.67%	500 $3,000
Q4 2020 Jan 21, 2021	SELL	$3.5 - $7.98 $2,800 - $6,384	-800 Reduced 57.14%	600 $3,000
Q3 2020 Oct 06, 2020	BUY	$4.78 - $16.97 $5,258 - $18,667	1,100 Added 366.67%	1,400 $9,000
Q2 2020 Jul 16, 2020	BUY	$1.68 - $8.85 $504 - $2,655	300 New	300 $3,000

103

35.8M

83.1K

120K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $45.5M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Optimum Investment Advisors, based on Form 13F filings with the SEC.

Stay updated on Optimum Investment Advisors with notifications on news.